The Center for the Evaluation of Value and Risk in Health's (CEVR) current projects include:
- Appraisal of the inter-country transferability of approaches to value assessment
- Assessing diagnosis and treatment delays and health care disparities by race/ethnicity among individuals with Alzheimer’s disease and related dementias
- Center of excellence in value assessment award
- Clinical and economic value of whole exome sequencing (WES) in rare and undiagnosed diseases
- Disinvestment opportunities for low-value care in commercially insured populations
- Evaluating accuracy in health technology assessments
- Examining lifetime costs and health benefits associated with chronic disease management
- Examining the impact of breakthrough therapy designation on health plan coverage decisions
- Exploring commercial health plan coverage of biosimilars
- How comprehensive are health plans’ evidence reviews in specialty drug coverage decisions
- Increasing the use of health economic information for global health
- Is orphan drug coverage associated with cost-effectiveness? An empirical study
- Racial and ethnic disparities in ADRD diagnosis, treatment and costs
- The influence of ICER reports on payers’ specialty drug coverage: An empirical analysis
- The social value of vaccines: A new look
- Value framework for major depression
- When are breakthrough therapies cost-effective?